What is MDxI?
MDxI, originally founded in 1993 as Service Strategies, is a market research firm that has evolved significantly over its history. Initially focused on customer satisfaction research for companies in the Dallas market, it expanded its services to serve Fortune 500 clients across Public Utilities, Financial Services, and Telecommunications. After an acquisition in 2002 and subsequent rebranding, the company pivoted its strategic direction in 2005 towards medical and scientific product research, with a notable emphasis on In Vitro Diagnostics. This strategic shift has positioned MDxI to capitalize on emerging opportunities within the healthcare and diagnostics sectors.
How much funding has MDxI raised?
MDxI has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in MDxI
PPP
Public-Private Partnership
What's next for MDxI?
The recent large-scale, late-stage funding indicates MDxI is poised for significant scaling and market penetration. This capital infusion is likely to fuel product development, expand research and development capabilities, and bolster market outreach efforts. The strategic investment suggests confidence from backers in MDxI's long-term vision and its capacity to innovate within the competitive diagnostics landscape. Future growth will likely involve strengthening its position in In Vitro Diagnostics and potentially exploring new therapeutic areas or technological advancements.
See full MDxI company page
